David Callanan

David Callanan

Company: Aviceda Therapeutics

Job title: Chief Medical Officer

Seminars:

Roundtables: Discussing Regulatory Challenges Across Different Stages of Dry AMD Therapeutics Development 4:15 pm

Some of the biggest challenges when developing drug for dry AMD is understanding the regulatory landscape for all stages of drug development. This session facilitates discussions on a range of regulatory checkpoints including: Pre-IND Endpoint Designation Recruiting & Phase I Phase II & Phase IIIRead more

day: Day Two

Exploring a Novel Approach Using a Glyco-Immune Therapy Targeting Both Complement and Macrophages 12:00 pm

A discussion of how macrophages/microglia are involved in the pathobiology of AMD What are Siglecs and self-associated molecular patterns and how do they modulate immune responses? A novel glyco-engineered nanoparticle that inhibits over-activation of complement and macrophagesRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.